Cargando…
Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
INTRODUCTION: The aim of this study was to investigate retinal thickness as a biomarker for identifying patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). METHODS: The retinal thickness, utilizing the spectral domain optical coherence tomography, was compared among 73 p...
Autores principales: | Tao, Rui, Lu, Zhaozeng, Ding, Ding, Fu, Shuhao, Hong, Zhen, Liang, Xiaoniu, Zheng, Li, Xiao, Yiqin, Zhao, Qianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558027/ https://www.ncbi.nlm.nih.gov/pubmed/31206006 http://dx.doi.org/10.1016/j.dadm.2019.04.003 |
Ejemplares similares
-
Retinal blood flow in mild cognitive impairment and Alzheimer's disease
por: Feke, Gilbert T., et al.
Publicado: (2015) -
Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: Case-control study and meta-analysis
por: Knoll, Brianna, et al.
Publicado: (2016) -
Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
por: den Haan, Jurre, et al.
Publicado: (2019) -
Retinal oxygen metabolism in patients with mild cognitive impairment
por: Olafsdottir, Olof Birna, et al.
Publicado: (2018) -
Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis
por: den Haan, Jurre, et al.
Publicado: (2017)